Richard Thorn
16Patents
5h-index
20Co-inventors
66Inventor score
Filing activity: Feb 3, 1986 → Nov 30, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4753873A | Peptides for the diagnosis of HTLV-III antibodies, their preparation and use | Emerging Cross-Sectional Technologies | 40 | Expired |
| US4734362A | Process for purifying recombinant proteins, and products thereof | Emerging Cross-Sectional Technologies | 29 | Expired |
| US6465431B1 | Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis | Chemistry; Metallurgy | 23 | Expired |
| US6586401B1 | Troponin subunit I fragment and homologs thereof | Chemistry; Metallurgy | 15 | Expired |
| US6589936B1 | Pharmaceutical compositions comprising recombinant troponin subunits | Human Necessities | 15 | Expired |
| US7452866B2 | Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit 1 | Chemistry; Metallurgy | 4 | Active |
| US8986653B2 | Labeled iodinated tropane formulation | Physics | 1 | Active |
| US11116852B2 | Frataxin expression constructs | Chemistry; Metallurgy | 1 | Active |
| US8574545B2 | Labeled iodinated tropane formulation | Physics | 1 | Active |
| US11998618B2 | Frataxin expression constructs | Chemistry; Metallurgy | 0 | Active |
| US7078385B2 | Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit I | Chemistry; Metallurgy | 0 | Expired |
| US11865188B2 | Gene therapy for AADC deficiency | Chemistry; Metallurgy | 0 | Active |
| US9757483B2 | Labeled iodinated tropane formulation | Physics | 0 | Active |
| US8133861B2 | Systemic purine administration: modulating axonal outgrowth of central nervous system neurons | Human Necessities | 0 | Active |
| US12409235B2 | Gene therapy for AADC deficiency | Chemistry; Metallurgy | 0 | Active |
| US10898585B2 | Gene therapy for AADC deficiency | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.